top of page

Fluidic Analytics' publication is selected for the ACS Editors' Choice

Congratulations to our resident, Fluidic Analytics, on being selected for the ACS Editors' Choice for their paper

"Antibody Affinity Governs the Inhibition of SARS-CoV-2 Spike/ACE2 Binding in Patient Serum"!

To view the article on Fluidic Analytics website, click here.

Comments

Featured Posts

Register for C2I's Vendors Exhibition & Demo Lab on 5/22/2024

Register for C2I's Vendors Exhibition & Demo Lab on 5/22/2024

CreaGen & C2I's CEO/Co-founder Recieves 2018 Henry A. Hill Award

CreaGen & C2I's CEO/Co-founder Recieves 2018 Henry A. Hill Award

CreaGen attends ACS Fall 2018 National Meeting!

CreaGen attends ACS Fall 2018 National Meeting!

C2I hosts exciting private summer social!

C2I hosts exciting private summer social!

CreaGen Life Science Incubator (C2I) is expanding!

CreaGen Life Science Incubator (C2I) is expanding!

6th Annual Advances in Chemical Sciences Symposium

6th Annual Advances in Chemical Sciences Symposium

Recent Posts

MassBio: Pharma Day with Daiichi Sankyo

C2I's 2024 Vendors Exhibition Day

The C2I team attends Nikon BioImaging Lab's Grand Opening

Register for C2I's Vendors Exhibition & Demo Lab on 5/22/2024

Join us for the Vendors Exhibition at C2I Accelerator: Wed, May 22, 2024; 11 AM-1 PM

C2I Family's 2023 Social Event Memories

We are excited to welcome our new member, Analog Devices!

Welcome to our member, 100X Bioassay!

We are extending a warm welcome to our new member, Fieldstone Bio, Inc.!

C2I Accelerator 2023 Summer Mixer

Follow Us

bottom of page